2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Disease Models, Animal in 10 studies
2,2-bis(4-glycidyloxyphenyl)propane: structure
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was undertaken to investigate the possible mechanism of curcumin-mediated beneficial effects in memory deficits associated with experimental dementia." | 7.76 | Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia. ( Jaggi, AS; Kaur, B; Rinwa, P; Singh, N, 2010) |
| "The present study was undertaken to investigate the possible mechanism of curcumin-mediated beneficial effects in memory deficits associated with experimental dementia." | 3.76 | Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia. ( Jaggi, AS; Kaur, B; Rinwa, P; Singh, N, 2010) |
| "Osteonecrosis was induced in rabbits in the model group and the BADGE group." | 1.48 | BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model. ( Fan, L; Ge, Z; Ji, W; Li, J; Li, M; Wang, K; Yuan, N, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Wang, Y | 2 |
| Pan, Z | 1 |
| Chen, F | 1 |
| Miyazaki, I | 1 |
| Kikuoka, R | 1 |
| Isooka, N | 1 |
| Takeshima, M | 1 |
| Sonobe, K | 1 |
| Arai, R | 1 |
| Funakoshi, H | 1 |
| Quin, KE | 1 |
| Smart, J | 1 |
| Zensho, K | 1 |
| Asanuma, M | 1 |
| Yuan, N | 1 |
| Li, J | 1 |
| Li, M | 1 |
| Ji, W | 1 |
| Ge, Z | 1 |
| Fan, L | 1 |
| Wang, K | 1 |
| Yin, Y | 1 |
| Hou, G | 1 |
| Li, ER | 1 |
| Wang, QY | 1 |
| Kang, J | 1 |
| He, Z | 1 |
| Deng, S | 1 |
| Morgenweck, J | 1 |
| Abdel-Aleem, OS | 1 |
| McNamara, KC | 1 |
| Donahue, RR | 1 |
| Badr, MZ | 1 |
| Taylor, BK | 1 |
| Rinwa, P | 1 |
| Kaur, B | 1 |
| Jaggi, AS | 1 |
| Singh, N | 1 |
| Kalonia, H | 1 |
| Kumar, P | 1 |
| Kumar, A | 1 |
| Weismann, D | 1 |
| Erion, DM | 1 |
| Ignatova-Todorava, I | 1 |
| Nagai, Y | 1 |
| Stark, R | 1 |
| Hsiao, JJ | 1 |
| Flannery, C | 1 |
| Birkenfeld, AL | 1 |
| May, T | 1 |
| Kahn, M | 1 |
| Zhang, D | 1 |
| Yu, XX | 1 |
| Murray, SF | 1 |
| Bhanot, S | 1 |
| Monia, BP | 1 |
| Cline, GW | 1 |
| Shulman, GI | 1 |
| Samuel, VT | 1 |
10 other studies available for 2,2-bis(4-glycidyloxyphenyl)propane and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Inhibition of PPARγ by bisphenol A diglycidyl ether ameliorates dexamethasone-induced osteoporosis in a mouse model.
Topics: Adipogenesis; Adiposity; Animals; Benzhydryl Compounds; Biomarkers; Bone Marrow; Bone Resorption; Co | 2019 |
Effects of maternal bisphenol A diglycidyl ether exposure during gestation and lactation on behavior and brain development of the offspring.
Topics: Animals; Anxiety; Behavior, Animal; Benzhydryl Compounds; Body Weight; Brain; Breast Feeding; Cell D | 2020 |
BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model.
Topics: Animals; Benzhydryl Compounds; Disease Models, Animal; Epoxy Compounds; Male; Methylprednisolone; Os | 2018 |
Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
Topics: Animals; Benzhydryl Compounds; Bronchi; Cell Survival; Cells, Cultured; Disease Models, Animal; Down | 2013 |
Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Brain Ischemia; Disease Models, Animal; Epoxy C | 2016 |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
Topics: Anilides; Animals; Benzhydryl Compounds; Brain; Central Nervous System Agents; Disease Models, Anima | 2010 |
Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia.
Topics: Acetylcholinesterase; Animals; Benzhydryl Compounds; Brain; Curcumin; Dementia; Disease Models, Anim | 2010 |
Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
Topics: Animals; Antioxidants; Benzhydryl Compounds; Body Weight; Corpus Striatum; Disease Models, Animal; E | 2010 |
Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-γ (PPAR-γ) activation in a rat model of insulin resistance.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Disease Models, Animal; Epoxy Compounds; G | 2011 |